Search results
Young adults are falling for sunscreen myths — including claims that SPF is harmful and drinking...
Yahoo Life Style via AOL· 6 hours ago“Data shows that sunscreen prevents cancer.” According to the Skin Cancer Foundation, regularly...
Your expert guide to melanomas and how to spot them
The Telegraph via Yahoo News· 5 days agoIf you have noticed a lingering spot somewhere on your skin, it would be wise not to dismiss it, especially if there’s something unusual about its...
Harry Jowsey reveals skin cancer diagnosis at age 26 — here’s what to know about the ‘scary’ disease
NY Post via Yahoo News· 4 days agoGetty Images The Centers for Disease Control and Prevention say that sun safety is key to reduce the...
Cancer diagnoses expected to increase by 77% by 2050
Journal-News, Hamilton, Ohio via Yahoo News· 20 hours agoApr. 30—Cancer diagnoses are expected to increase 77% worldwide by 2050 and new trends in the occurrence of human papillomavirus among cancer patients underscores ...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 7 days agoHe also noted Moderna and Merck began testing their combination in squamous cell carcinoma, a form...
...Therapy (DART) Opposes Move to Cancel Medicare Coverage for Nonsurgical Treatment of Nonmelanoma ...
Valley City Times Record· 2 days ago"The local coverage determination, or LCD, if finalized in its current form, would cause a significant, adverse impact on patient choice and access to care for the treatment of NMSC," DART President ...
Stereotactic Radiosurgery to Treat 15-Plus Brain Metastases?
Medscape· 1 day agoA large study supports the use of stereotactic radiosurgery in patients with 15 or more brain...
Prairie Fare: Are you taking care of your skin?
The Bismarck Tribune· 6 days ago“I thought you were wearing white knee socks,” someone said.
Moderna (MRNA) Gears Up for Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 2 days agoInvestors' focus will likely be on updates on Moderna's (MRNA) expected RSV vaccine launch and its...
TuHURA Biosciences to Present Its IFx-2.0 Personalized Cancer Vaccine Clinical Trial Results at the...
Digital Journal· 6 days ago("TuHURA"), a Phase 3 registration-stage immune-oncology company developing novel technologies to overcome resistance to cancer immunotherapy, today announced that its IFx ...